Sudden death prevention with implantable devices.
Passman
Rod
R
Department of Medicine/Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Ill, USA.
Kadish
Alan
A
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000517:prevention & control / Q000628:therapy*; D001919:Bradycardia / Q000150:complications / Q000628:therapy; D009202:Cardiomyopathies / Q000150:complications / Q000628:therapy; D002983:Clinical Competence; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable / Q000009:adverse effects / Q000191:economics / Q000523:psychology; D004868:Equipment Failure; D005544:Forecasting; D006801:Humans; D008133:Long QT Syndrome / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D017202:Myocardial Ischemia / Q000150:complications / Q000628:therapy; D010138:Pacemaker, Artificial / Q000009:adverse effects / Q000191:economics / Q000523:psychology; D018579:Patient Selection; D011446:Prospective Studies; D011788:Quality of Life; D012189:Retrospective Studies; D012306:Risk; D017180:Tachycardia, Ventricular / Q000150:complications / Q000628:therapy
D000319:Adrenergic beta-Antagonists